CGC Financial Services’s GSK GSK Stock Holding History

CGC Financial Services’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.3K	Hold	234	–	–	﹤0.01%	215
2026 Q2	$12.3K	Hold	234	–	–	﹤0.01%	216
2026 Q1	$12.9K	Hold	234	–	–	﹤0.01%	201
2025 Q4	$11.5K	Hold	234	–	–	﹤0.01%	221
2025 Q3	$10.1K	Hold	234	–	–	﹤0.01%	228
2025 Q2	$8.99K	Hold	234	–	–	﹤0.01%	220
2025 Q1	$9.06K	Hold	234	–	–	﹤0.01%	203
2024 Q4	$7.91K	Hold	234	–	–	﹤0.01%	215
2024 Q3	$9.6K	Hold	234	–	–	﹤0.01%	203
2024 Q2	$9.01K	Hold	234	–	–	﹤0.01%	209
2024 Q1	$10K	Hold	234	–	–	0.01%	208
2023 Q4	$8.67K	Hold	234	–	–	﹤0.01%	229
2023 Q3	$8.48K	Hold	234	–	–	0.01%	179
2023 Q2	$8.34K	Buy	+234	New	+$8.39K	0.01%	193

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dodge & Cox San Francisco, California $187B AUM 13.73% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

JTC Employer Solutions Trustee St Helier, Jersey $1.16B AUM 24.39% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $46.6B AUM 32.12% 1-Year Est. Return

CGC Financial Services's GSK Position: Q3 2026 in Review

CGC Financial Services held its GSK (GSK) position steady in Q3 2026 at 234 shares worth $11.3K. The position accounts for ﹤0.01% of the portfolio, ranked #215.

CGC Financial Services first reported a position in GSK in Q2 2023 and has held it in 14 quarters since. The position peaked at $12.9K in Q1 2026. 854 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

CGC Financial Services held 234 shares of GSK worth $11.3K as of Q3 2026.
CGC Financial Services left its GSK share count unchanged in Q3 2026.
GSK made up ﹤0.01% of CGC Financial Services's portfolio in Q3 2026, its #215 holding.
CGC Financial Services first reported a position in GSK in Q2 2023 and has held it in 14 quarters since.
CGC Financial Services's GSK position peaked at $12.9K in Q1 2026.
854 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on CGC Financial Services's 13F filing for Q3 2026, filed 13 Oct 2026.